Pharmacology of the AC AT Inhibitor Avasimibe (CI‐1011)

This publication has 72 references indexed in Scilit:

• The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression
  Atherosclerosis, 2001
• Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits
  British Journal of Pharmacology, 1999
• Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Effect of membrane environment on inhibition of acyl-CoA:Cholesterol acyltransferase by a range of synthetic inhibitors
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Hepatic and Adrenal Toxicity of a Novel Lipid Regulator in Beagle Dogs
  Fundamental and Applied Toxicology, 1995
• Differential effects of an acyl‐coenzyme A: cholesterol acyltransferase inhibitor on HDL‐induced cholesterol efflux from rat macrophage foam cells
  FEBS Letters, 1995
• Bile acid synthesis in hamster hepatocytes in primary culture: Sources of cholesterol and comparison with other species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Lipoprotein Lp(a). A risk factor for myocardial infarction.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• The role of acyl-CoA:cholesterol acyltransferase in the metabolism of free cholesterol to cholesteryl esters or bile acids in primary cultures of rat hepatocytes
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
• The Pathogenesis of Atherosclerosis — An Update
  New England Journal of Medicine, 1986